BISCAY trial for bladder cancer - trial design and its potential impact on clinical practice
Toxicities of immunotherapy and patient expectations in lung cancer
SECOMBIT – determining the order of sequential therapies in metastatic melanoma with BRAF mutations
The use of photopheresis for the treatment of cutaneous T-cell lymphoma
When can checkpoint inhibitors be used to treat urothelial carcinoma?